Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	39,345	18,372	11,957	5,036	7,472	5,693
Market Cap Growth	70.02%	53.65%	137.41%	-32.59%	31.26%	11.92%
Enterprise Value	41,599	20,352	14,091	6,817	8,617	6,631
Last Close Price	42.81	19.99	13.01	5.47	8.09	6.15
PE Ratio	-	-	-	287.58	31.99	22.52
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	39.53	17.82	8.48	2.16	2.52	2.41
PB Ratio	25.55	11.96	6.64	1.65	2.43	2.00
P/TBV Ratio	31.23	14.65	8.02	1.80	2.68	2.20
P/OCF Ratio	869.16	326.80	354.53	1611.41	2602.11	-
EV/Sales Ratio	41.80	19.74	9.99	2.92	2.90	2.81
EV/EBITDA Ratio	-	-	-	41.33	22.68	15.64
EV/EBIT Ratio	-	-	-	63.13	26.59	17.98
EV/FCF Ratio	-237.62	-	-	-	-	-
Debt / Equity Ratio	1.66	1.66	1.32	0.82	0.57	0.47
Debt / EBITDA Ratio	-	-	-	15.10	4.58	3.14
Asset Turnover	0.22	0.23	0.27	0.42	0.61	0.56
Inventory Turnover	0.62	0.62	0.85	0.56	0.60	0.45
Quick Ratio	0.25	0.25	0.29	0.72	0.52	0.67
Current Ratio	0.82	0.91	1.19	2.18	1.97	2.12
Return on Equity (ROE)	-12.23%	-15.83%	-51.43%	0.33%	7.81%	9.01%
Return on Assets (ROA)	-1.61%	-2.45%	-13.46%	1.20%	4.15%	5.41%
Return on Capital (ROIC)	-1.88%	-2.71%	-14.74%	1.30%	4.50%	5.94%
Return on Capital Employed (ROCE)	-	-	-	2.50%	9.40%	11.70%
Earnings Yield	-0.47%	-1.36%	-10.37%	0.35%	3.13%	4.44%
FCF Yield	-0.44%	-1.00%	-1.72%	-8.50%	-4.08%	-6.73%
Dividend Yield	-	-	-	0.09%	0.32%	-
Payout Ratio	-	-	-	708.02%	26.50%	27.08%
Buyback Yield / Dilution	-0.89%	-0.58%	-4.91%	6.27%	0.23%	0.24%
Total Shareholder Return	-	-0.58%	-4.91%	6.37%	0.55%	0.24%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.